The largest database of trusted experimental protocols

13 protocols using cd45 bv785

1

Immunophenotyping of ex vivo B cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated or ex vivo cultured human cells were washed in PBS with 5% bovine serum (FACS buffer) and subsequently stained for 30 minutes at 4°C with fluorophore conjugated antibodies against CD19, CD20, CD22, CD27, or IgD (all BD Biosciences). Cells were then washed twice in FACS buffer and analysed on a FACS Canto2 (BD Biosciences). Where appropriate dead cells were excluded using 4,6-Diamidin-2-phenylindol (DAPI; Thermo Fisher).
To analyse B cells after 9–11 days in culture, plates were spun at 400×g for 3 minutes, supernatants were taken for analysis by ELISA and cells in pellets were re-suspended and pooled for each condition. Cells were washed with PBS and stained with NIR fixable live/dead dye (Molecular probes) for 15 minutes at room temperature and washed with FACS buffer (2%BSA, 2mMEDTA, PBS). Live/dead staining was followed by an incubation with Fc Block reagent (BioLegend) for 10 minutes at RT and finally staining with a mix of labelled antibodies: CD45-BV785, CD19-FITC, CD27-BV711, CD38-APC, CD138-PE, and IgD-BV421 (all BioLegend) following the manufacturers recommendations for 30 minutes at 4C. Stained cells were washed and fixed with 2% PFA in PBS for 10 minutes at RT. Stained cells were analysed in a Beckton Dickinson Fortessa with 355, 405, 488, 561, and 633nm lasers.
+ Open protocol
+ Expand
2

Measuring Mitochondrial and Cytosolic Calcium Flux in NK92 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genetically encoded, mitochondria-targeted pScalps_CEPIA2mt calcium reporter was transduced into NK92 cells (American Type Culture Collection, CRL-2407), sorted by flow cytometry, and used to measure mitochondrial calcium flux via flow cytometry. To measure the cytosolic calcium levels, these NK92 cells were also loaded with 2 µM Indo-1-AM (Thermo Fisher Scientific) in the presence of Pluronic F-127 (Sigma-Aldrich) and 2.5 mM probenecid (Thermo Fisher Scientific) in HBSS (Life Technologies) with 2 mM calcium and 2% FCS for 30 min at 37°C. Subsequently, full α-MEM was added and incubated for another 30 min at ambient temperature to enable intracellular trapping of Indo-1. The loaded cells were surface stained with CD45-BV785 (BioLegend) and LIVE/DEAD near-infrared marker (Thermo Fisher Scientific) and washed once. Samples were kept on ice and warmed in a 37°C water bath for 3 min prior to acquisition. Data were acquired on a FACSymphony A5 (BD Biosciences) equipped with a UV laser. Calcium flux was triggered by adding MK6-83 or bafilomycin A1 as indicated in the graphs. Ionomycin (1 µM) was added at the end of the assay to show maximum responsiveness of the system. CEPIAmt fluorescence and the ratiometric Indo-1 fluorescence were collected in the FACSDiva flow cytometer (BD Biosciences), and the FCS files were exported to FlowJo (BD Biosciences) for further analysis.
+ Open protocol
+ Expand
3

Flow Cytometry Antibody Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in flow cytometry: B220 FITC 1:50 (BD Pharmingen, RA3-6B2), CD3 BV421 1:200 (17A2, BioLegend), CD3 FITC 1:50 (17A2, BD Pharmingen), CD3 PE-Cy-7 1:25 (145-2C11, BD Pharmingen), CD11b PerCP-Cy5.5 1:400 (M1/70, eBioscience), CD11b BV421 1:400 (M1/70, BioLegend), CD11b PE-Cy-7 1:400 (M1/70, eBioscience), CD11c BV421 1:100 (N418, BioLegend), CD16/32 unconjugated 10 μg ml−1 (93, BioLegend), CD19 BV421 (6D5, BioLegend), CD19 APC 1:400 (1D3, BD Pharmingen), CD45 BV421 1:400 (30-F11, BioLegend), CD45 BV785 1:400 (30-F11, BioLegend), CD49b APC 1:100 (DX5, BD Pharmingen), CD90.2 APC-Cy7 1:400 (30-H12, BioLegend), CD117 PE 1:800 (2B8, eBioscience), CD117 APC 1:800 (2B8, BD Pharmingen), CD117 BV711 1:800 (2B8, BioLegend), FcεRI APC 1:200 (MAR-1, eBioscience), Gr-1 BV421 1:800 (RB6-8C5, BioLegend), Gr-1 BV605 1:200 (RB6-8C5, BioLegend), IgE PE 1:100 (RME1, BioLegend), IgE BV786 1:100 (RME-1, BD Pharmingen), IgE BV421 1:100 (RME-1, BD Pharmingen), Ly6G PerCP-Cy5.5 1:100 (1A8, BD Pharmingen), MHCII A700 1:100 (M5/114.15.2, eBioscience), Siglec-F BV421 1:100 (E50-2440, BD Pharmingen), Siglec-F PE 1:100 (E50-2440, BD Pharmingen), Ter119 BV421 1:200 (Ter119, BioLegend), 5-HT unconjugated 0.11 μg ml−1 (5HT-H209, Dako) and mouse-IgG1 PE 1:100 (RMG1-1, BioLegend).
+ Open protocol
+ Expand
4

FACS-Based Microglia Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To sort microglia using FACS, cells were incubated with anti-rat CD16/CD32 antibodies (1:100, BD Biosciences) for 15 min on ice. Before antibody staining, samples were incubated with the Zombie NIR™ Fixable Viability Kit (BioLegend) for dead cell exclusion during FACS. Then cells were incubated with covalently conjugated fluorochromes for 45 min on ice in a shaker. Finally, cells were resuspended in 300 μl FACS buffer, and 30 μl of Precision Count Beads™ (BioLegend) were added to quantify the number of cells expressing markers of interest. Samples were run using BD FACSAria™ II (BD Bioscience) and analysed using FlowJo software (v10.1; Tree Start Inc.). Cells were sorted directly into a 1.5-ml Eppendorf tube containing 350 μl RLT buffer CD45-BV785 (0.5 μg/ml, clone 30-F11, BioLegend), CD11b-BV421 (0.5 μg/ml, clone M1/70, BioLegend), CX3CR1-AF488 (1 μg/ml, clone SA011F11, BioLegend), P2Y12-PE (1 μg/ml, clone S16007D, BioLegend), TLR4-PECy7 (1 μg/ml, clone SA15-21, BioLegend), MHCII-PerCp/Cy5.5 (1 μg/ml, clone M5/114, BioLegend), CD11c-BV650 (2 μg/ml, clone N418, BioLegend), MerTK-BV605 (1 μg/ml, clone 2B10C42, BioLegend), CCR2-BV711 (0.5 μg/ml; Clone 475301, BD Bioscience), Ly6C-APC (1 μg/ml, clone HK1.4, Thermo Fisher Scientific). The number of live cells (Zombie NIR negative) in sorting experiments was 39,902 ± 7234.
+ Open protocol
+ Expand
5

Comprehensive Immune Profiling of CT26 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
CT26 tumors were digested using a gentleMACS dissociator and a murine tumor dissociation kit (Miltenyi Biotec). Absolute viable cell counts were determined by propidium iodide staining and analysed on the MACSQuant analyzer. Cells from CT26 tumors and splenocytes were stained with fixable LIVE/DEAD blue (Life Technologies) and incubated with anti-mouse CD16/CD32 (eBioscience) prior to addition of anti-mouse: CD8-Pe-Cy7 (clone 53–6.7); CD3-eFluor 450 (clone 17A2); CD11c-PE (clone N418); CD86-FITC (clone GL1); PDCA1-APC (clone 129c) (eBioscience); PD-L1-BV421 (clone 10F.9G2); I-A/I-E (MHCII) (clone M5/114.15.2); B220-BV605 (clone RA3-6B2) (Biolegend); CD45-BV785 (clone 30F11); CD4-BUV395 (clone GK1.5); CD11b-BUV395 (clone M1/70); Ly6G-APC-Cy7 (clone 1A8); Ly6C-PerCP-Cy5.5 (clone AL-21) (BD Biosciences). For intracellular staining, cells were permeabilized using Foxp3 / Transcription Factor Staining Buffer Set (eBioscience) and incubated with anti-mouse Foxp3-PE (clone FJK-16S) and Ki67-eFluor 660 (clone SolA15) (eBioscience). Stained cells were fixed in 3.7% formaldehyde and analyzed using a BD LSRFortessa (BD Bioscience). Data analysis was performed using FlowJo (FlowJo LLC). 8 mice per treatment group were included in all flow cytometry analyses.
+ Open protocol
+ Expand
6

Multiparameter Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
PD-1 FITC (1:300; J43; eBioscience), NK1.1 PE (1:300; PK136; eBioscience), CD3e PE-Dazzle594 (1:300; 145-2C11; BioLegend), CD3e PE (1:200; 145-2C11; eBioscience), FoxP3 PerCP-Cy5.5 (1:200; FJK-16s; eBioscience), CD8a PE-Cy7 (1:2000; 53-6.7; eBioscience), CD8a APC (1:600; 53-6.7; eBioscience), CD8a PerCP-Cy5.5 (1:400; 53-6.7; eBioscience), TCRb AF700 (1:100; H57-597; BioLegend), CD45 BV785 (1:1000; 30-F11; BioLegend), CD4 BV711 (1:400; GK1.5; BioLegend), CD19 BV650 (1:400; 6D5; BioLegend), CD19 PE (1:500; 1D3; eBioscience), CD11b BV605 (1:1000; M1/70; BioLegend), CD11b BV510 (1:400; M1/70; BioLegend), CD11c BV605 (1:400; N418; BioLegend), Siglec-F PE (1:300; E50-2440; BD Biosciences), F4/80 APC (1:200; BM8; BioLegend), Ly-6G AF 700 (1:300; 1A8; BioLegend), MHC II BV650 (1:4000; M5/114.15.2; BioLegend), CD64 BV421 (1:200; X54-5/7.1; BioLegend), TNF FITC (1:300; MP6-XT22; BioLegend), IFNg PE-Cy7 (1: 1000; XMG1.2; BD Biosciences), Eomes PE (1:200; W17001A; BioLegend), Ki-67 BV 650 (1:200, 11F6; Biolegend), GzmB FITC (1:100; GB11; BioLegend). Gating strategy is depicted in Supplementary Fig. 6d.
+ Open protocol
+ Expand
7

Flow Cytometry Analysis of Murine Toxoplasma Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometric analyses, C57BL/6 mice were infected with 200 TgVEG WT-GFP-LUC or TgVEGΔROCY1-GFP-LUC parasites in 200 µL of PBS via intraperitoneal injection. At day 28 post-infection, mice were transcardially perfused with 50 mL of 1X PBS to remove non-adherent blood cells. Brains were harvested and digested using Dispase II (Roche Applied Science) diluted in Hepes-buffered saline. To remove myelin, 35% and 75% percoll (GE Healthcare) gradients were used. To block non-specific binding of antibodies to immune cells, the isolated cells were resuspended in 10% TrueStain FcX Buffer (BioLegend) in staining buffer (3% fetal bovine serum in 1X PBS). Cells were surface-stained with fluorescent dye-conjugated antibodies diluted in staining buffer (Biolegend: Ly6G:BV510 Cat#127633, CD11b:BV605 Cat#101257, CD45:BV785 Cat#103149, Ly6C:PerCp-Cy5.5 Cat#128017, CD3:APC-Cy7 Cat#100222). Cells were then resuspended in 1X PBS and run on the Novocyte flow cytometer (Agilent). Flow cytometry data were analyzed and graphically represented utilizing FlowJo software (Treestar), and the gating strategy is outlined in Fig. S6.
+ Open protocol
+ Expand
8

Measuring Mitochondrial and Cytosolic Calcium Flux in NK92 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The genetically encoded, mitochondria-targeted pScalps_CEPIA2mt calcium reporter was transduced into NK92 cells (American Type Culture Collection, CRL-2407), sorted by flow cytometry, and used to measure mitochondrial calcium flux via flow cytometry. To measure the cytosolic calcium levels, these NK92 cells were also loaded with 2 µM Indo-1-AM (Thermo Fisher Scientific) in the presence of Pluronic F-127 (Sigma-Aldrich) and 2.5 mM probenecid (Thermo Fisher Scientific) in HBSS (Life Technologies) with 2 mM calcium and 2% FCS for 30 min at 37°C. Subsequently, full α-MEM was added and incubated for another 30 min at ambient temperature to enable intracellular trapping of Indo-1. The loaded cells were surface stained with CD45-BV785 (BioLegend) and LIVE/DEAD near-infrared marker (Thermo Fisher Scientific) and washed once. Samples were kept on ice and warmed in a 37°C water bath for 3 min prior to acquisition. Data were acquired on a FACSymphony A5 (BD Biosciences) equipped with a UV laser. Calcium flux was triggered by adding MK6-83 or bafilomycin A1 as indicated in the graphs. Ionomycin (1 µM) was added at the end of the assay to show maximum responsiveness of the system. CEPIAmt fluorescence and the ratiometric Indo-1 fluorescence were collected in the FACSDiva flow cytometer (BD Biosciences), and the FCS files were exported to FlowJo (BD Biosciences) for further analysis.
+ Open protocol
+ Expand
9

Cell Sorting and ICP-MS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorting of human cells was performed using the following antibodies: CD31-PE-Cy7 (BioLegend, 303118), CD44-AF647 (Novus Biologicals, NB500–481AF647), CD45-BV785 (BioLegend, 304048). The sorted cells corresponded to CD45neg/CD31neg/CD44pos cells and CD45neg/CD31neg/CD44neg cells and were isolated on a FACSAria Fusion (BD). ICP-MS experiments were conducted in CD44pos and CD44neg tumour cells as described in the ICP-MS section. Sorting of murine cells was performed using the following antibodies: CD44-AF647 (Biolegend, 103018), MHCII-APC/Cyanine7 (BioLegend, 107628). The sorted cells corresponded to MHCIIpos/CD44pos cells and MHCIIpos/CD44neg cells. Sorted cells were centrifuged at 300× g and cell pellets were processed for subsequent applications.
+ Open protocol
+ Expand
10

Evaluating Q702 and Anti-PD-1 in B16-OVA Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female C57BL/6 mice aged between 7 and 8 weeks were purchased from Shanghai Lingchang Biotechnology Co., LTD, China. B16-OVA tumor cells (2 × 105) were implanted subcutaneously (s.c.) into the right flank of mice. When tumor size reached 50 mm3, mice were randomized and treated intraperitoneally with the vehicle or 30 mg/kg Q702 (orally every day) with or without 10 mg/kg anti-PD-1 antibody twice a week. On day 9, tumor samples were collected and processed as single-cell suspensions. Cells were stained with CD45-BV785 (BioLegend; #103149, clone 30-F11), CD3-BUV395 (BD Biosciences; #740268, clone 17A2), CD4-BV421 (BioLegend; #100438, clone GK1.5), CD8-FITC (MBL International Corporation, Woburn, MA, USA; #D271-4, clone KT15), and SIINFEKL-H-2Kb OVA tetramer-PE (MBL International Corporation; #TB-5001-1). Stained samples were analyzed using BD FACS LSR Fortessa flow cytometry, and all data were analyzed using FlowJo software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!